Bioanalytical method for the simultaneous quantification of irinotecan and its active metabolite SN-38 in mouse plasma and tissue homogenates using HPLC-fluorescence-Reference-Cited by-同舟云学术

Bioanalytical method for the simultaneous quantification of irinotecan and its active metabolite SN-38 in mouse plasma and tissue homogenates using HPLC-fluorescence

Published:2020-07 Issue: Volume:1149 Page:122177
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Martínez-Chávez Alejandra,Rosing Hilde,Gan Changpei,Wang Yaogeng,Schinkel Alfred H.,Beijnen Jos H.

Funder

CONACyT

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference16 articles.

1. Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics;de Man;Clin. Pharmacokinet.,2018

2. Irinotecan and its active metabolite, SN-38: Review of bioanalytical methods and recent update from clinical pharmacology perspectives;Mullangi;Biomed. Chromatogr.,2010

3. Carboxylesterases: Structure, function and polymorphism;Satoh;Biomol. Ther.,2009

4. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2;Humerickhouse;Cancer Res.,2000

5. Liquid chromatographic-tandem mass spectrometric assay for the simultaneous quantification of Camptosar® and its metabolite SN-38 in mouse plasma and tissues;Bardin;J. Chromatogr. A.,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of nanocarrier mediated afatinib pharmacokinetic: A comparative in-vivo study in rat model for enhanced therapeutic efficacy in lung cancer management;Journal of Drug Delivery Science and Technology;2024-05

2. IRINOTECAN-REVIEW OF ANALYTICAL METHODS DEVELOPED FOR PHARMACEUTICAL DOSAGE FORMS AND BIOLOGICAL FLUIDS;International Journal of Applied Pharmaceutics;2023-11-07

3. A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy;Biomaterials;2023-11

4. Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development;Biomedicine & Pharmacotherapy;2023-08

5. Metal-organic framework for biomimetic nitric oxide generation and anticancer drug delivery;Biomaterials Advances;2023-02